ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2026
Cutoffs for serum mold-specific IgG levels for hypersensitivity pneumonitis: a diagnostic test accuracy study of 219 subjects.
Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmerican Thoracic Society guidelines suggest serum specific IgG (sIgG) testing targeting potential antigens associated with hypersensitivity pneumonitis (HP). The diagnostic cutoffs of mold-sIgGs remain undefined and their performance based on pre- and post-test probabilities remain untested.
methodsWe conducted a diagnostic test accuracy study using a case-control design. We enrolled subjects with HP (cases), other interstitial lung diseases (ILDs, diseased controls), and healthy controls with/without mold exposure. We measured sIgG against Aspergillus fumigatus, Penicillium chrysogenum, Cladosporium herbarum, and Micropolyspora faeni using an automated, fluorescent enzyme immunoassay. Cutoffs were derived from the 95th percentile values among non-exposed healthy controls for individual sIgGs and Youden's J-statistic for pooled sIgG (sum of four levels). We evaluated the performance characteristics of sIgG levels for HP diagnosis among subjects with ILDs.
resultsWe included 219 subjects (mean age, 51.4 years; 50.2% women): 105 HP, 64 non-HP ILDs, and 50 healthy controls (25 non-exposed, 25 exposed). Cutoffs (mgA/L) were 33, 22, 34, 8, and 53, for A. fumigatus, P. chrysogenum, C. herbarum, M. faeni, and pooled sIgG levels, respectively. The 4-mold panel (positive if any sIgG exceeded cutoff) showed 57.1% sensitivity and 78.1% specificity for HP diagnosis among ILD subjects. The pooled sIgG test (positive likelihood ratio, 3.29; negative likelihood ratio, 0.51) shifted post-test probability of HP diagnosis from 44% (for a negative test) to 84% (for a positive test).
conclusionMold-specific IgGs, when used at our proposed cutoffs, significantly alter post-test diagnostic probabilities; thus, can be used as an adjunct in multi-component HP diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.